Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer

Shaopeng Zhang
Ximo Xu
Kundong Zhang
Changzheng Lei
Yitian Xu
Pengshan Zhang
Yuan Zhang
Haitao Gu
Chen Huang
Zhengjun Qiu

Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

@yzll's saved articles (yzll)

Log in to save this article

Abstract

No abstract available

Version published to 10.1007/s00262-024-03898-w
Dec 30, 2024
Version published to 10.1101/2024.08.07.24311609 on medRxiv
Aug 8, 2024

Targeting SIRT7 shape an immune-activated microenvironment by both promoting CCL5-induced TILs infiltration and decreasing PD-L1 expression

This article has 3 authors:
1. Sohail Khan
2. Iltaf Khan
3. Sumreen Sohail
This article has no evaluationsLatest version Dec 30, 2025
Alantolactone inhibits T-cell lymphoma progression by suppressing CD47 expression via the PI3K/AKT and ERK signaling pathways

This article has 9 authors:
1. Xiaodong Li
2. Ningbo Pang
3. Yingcong Chen
4. Tingting Pan
5. Wenwen Sun
6. Bingrong Chen
7. Fuyi Xie
8. Yinyu Mu
9. Ni Li
This article has no evaluationsLatest version Jan 9, 2026
Targeting MDA5 enhances tumor immunity through immunogenic cell death and augments the efficacy of immune checkpoint blockade

This article has 19 authors:
1. wenyu wang
2. zhitong Niu
3. Bing Cheng
4. yue Jiang
5. Yingzhen Weng
6. Qian Xiao
7. Guojie Long
8. chaoyin Wei
9. Qiufeng Liu
10. jinxin Chen
11. xiaofeng Wen
12. yufeng Chen
13. panpan Wang
14. Yan Huang
15. Jing Tan
16. Weidong Pan
17. Ronghua Zhang
18. Qiang Yu
19. Xiaojian Wu
This article has no evaluationsLatest version Dec 9, 2025